Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
Eli Lilly 's LLY tirzepatide, which is marketed as Mounjaro for diabetes and Zepbound for obesity, succeeded in late-stage studies for obstructive sleep apnea (OSA). AbbVie 's ABBV phase III study on its successful drug Rinvoq (upadacitinib) for treating giant cell arteritis (“GCA”) met its primary endpoint and key secondary endpoints. Roche 's RHHBY combination study evaluating its marketed lymphoma drug, Columvi, for earlier line of use met its primary endpoint of overall survival (“OS”). Recap of the Week's Most Important Stories J&J Begins Q1 Earnings Season: J&J's first-quarter results were mixed as it beat estimates for earnings but missed the same for sales. Higher sales of key products such as Darzalex, Stelara, Tremfya, Uptravi and Erleada drove the segment's growth. New drugs like Carvykti, Tecvayli and Spravato also contributed to growth. The growth was partially dampened by lower sales of Imbruvica, COVID-19 vaccine and generic/biosimilar competition to drugs like Zyti
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Eli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Novo Trades at Hefty Discount to Lilly Even After 350% Rally [BNN Bloomberg (Canada)]BNN Bloomberg
- Eli Lilly and Company (NYSE:LLY) Just Released Its First-Quarter Earnings: Here's What Analysts Think [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk raises 2024 outlook as company races to boost output of Wegovy weight-loss drug [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Denmark's Novo Nordisk forecasts 27% sales surge but faces price pressure amid Eli Lilly competition [Fortune]Fortune
LLY
Earnings
- 4/30/24 - Beat
LLY
Sec Filings
- 4/30/24 - Form 10-Q
- 4/30/24 - Form 8-K
- 4/16/24 - Form 4
- LLY's page on the SEC website